RecruitingNot ApplicableNCT07449416

Ceribell Delirium Monitor Outcomes Pilot Study

Sponsor

Ceribell Inc.

Enrollment

100 participants

Start Date

Mar 15, 2026

Study Type

INTERVENTIONAL

Conditions

Delirium in the Intensive Care Unit

Summary

This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Ceribell Delirium Monitoring System for people with delirium in the intensive care unit. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECeribell Delirium Monitoring System

The Ceribell Delirium Monitor provides an assessment of delirium every 15 minutes during each EEG recording and provides a trend graph depicting the output of the algorithm. If delirium is detected, a CAM-ICU assessment will be performed to confirm the presence of delirium. The patient's care team will use the additional data provided by the Ceribell Delirium Monitor to inform decisions regarding alterations in the patient's delirium management.

Locations(2)

University of California Irvine

Irvine, California, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07449416

Related Trials

Digital and Plasma Biomarkers in Delirium

NCT076942062 locations

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

NCT076498761 location